Researchers Examine Cost-Effectiveness Of Different Genetic Tests For Epilepsy.

March 01, 2019

Neurology Advisor (2/28, May) reports researchers found in a cost-effectiveness analysis “that an epilepsy panel (EP) with deletion/duplication testing as well as whole-exome sequencing (WES) represent the most cost-effective genetic tests for epilepsy, p...